Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue engineering: from basic science to products: a preface.

Tissue engineering·2009
Same author

International workshop on clearance of TSE agents from blood products and implanted tissues.

Biologicals : journal of the International Association of Biological Standardization·2000
Same author

Bioartificial organs as outcomes of tissue engineering. Scientific and regulatory issues.

Annals of the New York Academy of Sciences·1998
Same author

Adventitious agents from animal-derived raw materials and production systems.

Developments in biological standardization·1996
Same author

Prevalence of viremia in human immunodeficiency virus-infected patients with renal disease.

Archives of internal medicine·1995
Same author

Biotechnology applications in biomaterials.

Journal of cellular biochemistry·1994

Related Experiment Video

Updated: Jun 19, 2026

Experimental Approaches to Tissue Engineering
16:41

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

Biomedical applications of tissue engineering technology: regulatory issues.

K B Hellman1

  • 1Center for Devices and Radiological Health, U.S. Food and Drug Administration, Rockville, Maryland 20852.

Tissue Engineering
|November 3, 2009
PubMed
Summary

The U.S. Food and Drug Administration (FDA) is adapting its regulatory processes for novel tissue engineering products. New procedures streamline reviews for combination products, ensuring public health and product safety.

More Related Videos

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink
08:34

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink

Published on: April 21, 2016

Tissue Engineering of a Human 3D in vitro Tumor Test System
11:12

Tissue Engineering of a Human 3D in vitro Tumor Test System

Published on: August 6, 2013

Related Experiment Videos

Last Updated: Jun 19, 2026

Experimental Approaches to Tissue Engineering
16:41

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink
08:34

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink

Published on: April 21, 2016

Tissue Engineering of a Human 3D in vitro Tumor Test System
11:12

Tissue Engineering of a Human 3D in vitro Tumor Test System

Published on: August 6, 2013

Area of Science:

  • Biomedical Engineering
  • Regulatory Science
  • Materials Science

Background:

  • Novel technologies like tissue engineering are increasingly used in FDA-regulated biomedical products.
  • The FDA ensures the safety and effectiveness of pharmaceuticals and medical devices through scientific assessment.
  • Existing regulatory frameworks require adaptation for interdisciplinary technologies.

Purpose of the Study:

  • To outline the FDA's evolving approach to regulating emerging technologies, specifically tissue engineering.
  • To describe new procedures for evaluating combination products and resolving regulatory jurisdiction.
  • To identify generic safety and effectiveness issues for the tissue engineering product development community.

Main Methods:

  • Implementation of legislative and regulatory changes to simplify administrative processes.
  • Designation of a lead FDA center for product review based on the primary mode of action.
  • Increased cooperation and information sharing among FDA centers, including the InterCenter Tissue Engineering Initiative.

Main Results:

  • New procedures allow for lead center designation and collaborative reviews for combination products.
  • The FDA InterCenter Tissue Engineering Working Group has developed a Draft Report on tissue engineering issues.
  • Generic safety and effectiveness considerations have been identified for product developers.

Conclusions:

  • The FDA is enhancing its regulatory strategies to accommodate innovative technologies like tissue engineering.
  • Collaborative approaches and clear guidance are crucial for evaluating complex biomedical products.
  • The FDA utilizes research, monitoring, guidance, education, and partnerships to ensure product safety and effectiveness.